[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557787":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":34,"centralContacts":38,"locations":48,"responsibleParty":67,"collaborators":10,"id":71,"slug":10,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":10,"eligibilityCriteria":75,"healthyVolunteers":72,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":50,"whyStopped":10,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"The First Affiliated Hospital with Nanjing Medical University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"CTO-PCI group",null,"successful percutaneous coronary intervention (PCI)",[13,14],"Procedure: PCI","Drug: OMT",{"label":16,"type":10,"description":17,"interventionNames":18},"CTO-OMT group","optimal medical therapy (OMT)",[14],[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","PCI","successful percutaneous coronary intervention (PCI) in Coronary chronic total occlusions (CTOs) patients",[9],[26],"percutaneous coronary intervention",{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"DRUG","OMT","optimal medical therapy (OMT) in CTO patients, such as aspirin 1td, ACEI\u002FARB 1td, β blocker 1td, statin 1td.",[16,9],[33],"optimal medical therapy",[35],{"name":36,"affiliation":5,"role":37},"Leilei Chen","STUDY_DIRECTOR",[39,44],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},"Mei Wang","CONTACT","0086 15256095215","1513267113@qq.com",{"name":45,"role":41,"phone":46,"phoneExt":10,"email":47},"Lei Jiang","0086 18705501372","2771248705@qq.com",[49],{"facility":5,"status":50,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"RECRUITING","Nanjing","Jiangsu","210009","China","CN",{"type":57,"coordinates":58},"Point",[59,60],118.77778,32.06167,{"lat":60,"lon":59},[63,65],{"name":45,"role":41,"phone":64,"phoneExt":10,"email":47},"+8618705501372",{"name":40,"role":41,"phone":66,"phoneExt":10,"email":43},"+8615256095215",{"type":68,"investigatorFullName":69,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Chen Leilei","Director","100557787",false,"NCT06542653","Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion","Inclusion Criteria:\n\n* patients with at least one coronary CTO lesion at our hospital in between January 2011 and December 2017\n\nExclusion Criteria:\n\n* (1) patients with ST-segment elevation myocardial infarction (STEMI)\n* (2)a history of coronary artery bypass grafting (CABG)\n* (3) cardiogenic shock\n* (4) malignant tumor. Patients were referred for PCI based on CTO-related symptoms or evidence of viability, or corresponding ischemia in the area of the CTO artery.","ALL","18 Years","75 Years",{"count":80,"type":81},258,"ESTIMATED","OBSERVATIONAL","Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.",[85],"Coronary Atheroscleroses",[87,88,89],"Chronic total occlusion","Percutaneous coronary intervention","Major adverse cardiovascular events","2024-12-23",{"date":92,"type":93},"2024-12-27","ACTUAL",{"date":95,"type":93},"2023-09-17",{"date":97,"type":81},"2025-09-17",{"name":5,"class":6},1]